Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.68 |
| ▸ | RAB9A | P51151 | 4/20 | 0.66 |
| ▸ | MAOA | P21397 | 2/20 | 0.66 |
| ▸ | MAOB | P27338 | 2/20 | 0.66 |
| ▸ | NPC1 | O15118 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 5/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 5/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | ABAT | P80404 | 1/20 | 0.58 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL322544 | 0.98 | KMT2A (0.66) | KMT2ARAB9AMAOAMAOBNPC1 | |
| SCHEMBL15224205 | 0.89 | KMT2A (0.68) | KMT2ARAB9AMAOAMAOBNPC1 | |
| SCHEMBL8956279 | 0.88 | KMT2A (0.78) | KMT2ARAB9AMAOAMAOBNPC1 | |
| SCHEMBL3013357 | 0.86 | KMT2A (0.64) | KMT2ARAB9AMAOAMAOBNPC1 | |
| SCHEMBL27812099 | 0.84 | ALDH1A1 (0.64) | KMT2ARAB9AMAOAMAOBNPC1 | |
| SCHEMBL5138189 | 0.82 | KMT2A (0.73) | KMT2ARAB9AMAOAMAOBNPC1 | |
| SCHEMBL20109299 | 0.81 | KMT2A (0.68) | KMT2ARAB9AMAOAMAOBNPC1 | |
| SCHEMBL5458013 | 0.81 | KMT2A (1.00) | KMT2ARAB9AMAOAMAOBNPC1 | |
| SCHEMBL1520437 | 0.79 | RAB9A (1.00) | KMT2ARAB9AMAOAMAOBNPC1 | |
| SCHEMBL18243810 | 0.79 | KMT2A (0.71) | KMT2ARAB9AMAOAMAOBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116947868-A | Novel reactive fluorescent probe capable of specifically recognizing mercury ions, preparation method thereof and application of novel reactive fluorescent probe in detection of mercury ions | 辽宁大学 | 2023-10-27 | — | — | CN | claimed |
| CN-108204951-A | A kind of photoacoustic imaging probe and its preparation method and application | 深圳大学 | 2018-06-26 | — | — | CN | claimed |
| EP-1971600-B1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK BIOPHARMACEUTICALS CO LTD (KR) | 2013-08-21 | — | — | EP | claimed |
| US-20090131336-A1 | Isoxazole Derivatives and Use Thereof | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2009-05-21 | — | — | US | claimed |
| CN-116947868-B | Novel reactive fluorescent probe capable of specifically recognizing mercury ions, preparation method thereof and application of novel reactive fluorescent probe in detection of mercury ions | 辽宁大学 | 2025-08-19 | — | — | CN | disclosed |
| CN-116947868-A | Novel reactive fluorescent probe capable of specifically recognizing mercury ions, preparation method thereof and application of novel reactive fluorescent probe in detection of mercury ions | 辽宁大学 | 2023-10-27 | — | — | CN | disclosed |
| CN-116947868-A | Novel reactive fluorescent probe capable of specifically recognizing mercury ions, preparation method thereof and application of novel reactive fluorescent probe in detection of mercury ions | 辽宁大学 | 2023-10-27 | — | — | CN | disclosed |
| CN-108204951-A | A kind of photoacoustic imaging probe and its preparation method and application | 深圳大学 | 2018-06-26 | — | — | CN | disclosed |
| US-8653259-B2 | Process for synthesizing heterocyclic compounds | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2014-02-18 | — | — | US | disclosed |
| EP-1971600-B1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK BIOPHARMACEUTICALS CO LTD (KR) | 2013-08-21 | — | — | EP | disclosed |
| US-20090131336-A1 | Isoxazole Derivatives and Use Thereof | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2009-05-21 | — | — | US | disclosed |
| EP-1971600-A1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK Holdings Co., Ltd. (KR) | 2008-09-24 | — | — | EP | disclosed |
| US-20080146797-A1 | PROCESS FOR SYNTHESIZING HETEROCYCLIC COMPOUNDS | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2008-06-19 | — | — | US | disclosed |
| WO-2007078113-A1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK HOLDINGS CO., LTD. (KR) | 2007-07-12 | — | — | WO | disclosed |
| CN-1795178-A | Process for synthesizing heterocyclic compounds | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-06-28 | — | — | CN | disclosed |
| US-20040242560-A1 | Process for synthesizing heterocyclic compounds | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-12-02 | — | — | US | disclosed |
| US-4810725-A | ADRENERGIC BLOCKING AGENTS | MERCK & CO., INC. (US) | 1989-03-07 | — | — | US | disclosed |
| US-4593039-A | Beta blockers; cardiovascular disorders | MERCK & CO., INC. (US) | 1986-06-03 | — | — | US | disclosed |
| US-3931216-A | Process for the manufacture of 2-arylamino-2-imidazoline derivatives and their salts | BOEHRINGER INGELHEIM GMBH (DT) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080146797-A1 | PROCESS FOR SYNTHESIZING HETEROCYCLIC COMPOUNDS | TST, NISCH, CLIC4 | KMT2A 1586/4885RAB9A 2630/4885MAOA 2548/4885 |
| US-20090131336-A1 | Isoxazole Derivatives and Use Thereof | WNT3A, WNT1, WNT3 | KMT2A 4661/4885RAB9A 2013/4885MAOA 2376/4885 |
| US-20040242560-A1 | Process for synthesizing heterocyclic compounds | TST, NISCH, CLIC4 | KMT2A 1781/4885RAB9A 2415/4885MAOA 2446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.